The impact of pomegranate juice, lemon juice and secanjabin (a solution made by mixing vinegar, sugar and mint)on removing intrusive activity from the liver in myocardial imaging.

Evaluation of the pomegranate juice, lemon juice and secanjabin impact on removing intrusive activity from the liver in myocardial imaging with Technetium99m-Methoxyisobutylisonitrile in comparison with fatty food

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014062117684N4

Enrollment

100

Registered

2014-11-19

Start date

2014-11-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial imaging.

Interventions

Intervention 1: Intervention group(1): Drinking 200 cc of pomegranate juice, 10-15 min after radiopharmaceutical administration. Intervention 2: Intervention group(2):Drinking 200 cc of lemon juice, 1

Diagnosis

Intervention group(1): Drinking 200 cc of pomegranate juice, 10-15 min after radiopharmaceutical administration.

Intervention group(2):Drinking 200 cc of lemon juice, 10-15 min after radiopharmaceutical administration.

Intervention group(3):Drinking 200 cc of Secanjabin, 10-15 min after radiopharmaceutical administration.

Control group: using 100 gr of fatty food , 10-15 min after radiopharmaceutical administration.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients who refer by cardiologists to Namazi nuclear medicine center for performing perfusion scan with possibility of existence of ischemic heart diseases.; Patients who have signed the entrance form of the study. Exclusion criteria: Having approved liver diseases which can affect the study results.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Amount of clearing the intrusive activity of the liver. Timepoint: 30 and 50 minutes after administering radioactive substance. Method of measurement: Measuring Heart/Liver ratio.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNuclear medicine and molecular imaging research center

Shiraz university of medical science

nmmirc@yahoo.com+98 71 1612 5330

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026